Literature DB >> 17483142

A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.

Maria Maniati1, Alexandros Ikonomidis, Paraskevi Mantzana, Alexandros Daponte, Antonios N Maniatis, Spyros Pournaras.   

Abstract

OBJECTIVES: A Pseudomonas aeruginosa clinical isolate that exhibited high-level carbapenem resistance and produced metallo-beta-lactamase (MBL) was recovered from a Greek patient. This study was conducted to determine the underlying mechanisms that conferred the carbapenem resistance phenotype.
METHODS: MICs were determined by Etest and Etest MBL. PCR assays were performed for identification of bla(VIM-type), other antibiotic resistance and efflux pump genes and mapping of class 1 integrons. Expression of efflux pump genes was quantified by real-time PCR. Nucleotide sequencing was used to determine the bla(VIM) allele. The location of the MBL allele was investigated by mating experiments, plasmid analysis and hybridization studies.
RESULTS: The isolate was highly carbapenem-resistant (MICs of imipenem and meropenem were 512 and 128 mg/L, respectively) and multidrug-resistant. It harboured the beta-lactamase genes bla(VIM-4) and bla(P1b) in a novel class 1 integron named InV4P1, and a second integron with aac(6')-Ib and bla(OXA-35) gene cassettes. The isolate was deficient in porin OprD and overexpressed efflux pumps MexAB-OprM and MexXY-OprM. Conjugation experiments failed to detect transferable MBL determinants, plasmids were not visualized and bla(VIM) was detected by PCR in the chromosomal band.
CONCLUSIONS: Multiple carbapenem resistance mechanisms are demonstrated to coexist in a single P. aeruginosa isolate and might confer the high-level carbapenem resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483142     DOI: 10.1093/jac/dkm126

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.

Authors:  Spyros Pournaras; Ioulia Kristo; Georgia Vrioni; Alexandros Ikonomidis; Aggeliki Poulou; Dimitra Petropoulou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

2.  Hidden VIM-1 metallo-beta-lactamase phenotypes among Acinetobacter baumannii clinical isolates.

Authors:  Alexandros Ikonomidis; Eleni Ntokou; Antonios N Maniatis; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

Review 3.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Identification and distribution of the clinical isolates of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase and/or class 1 integron genes.

Authors:  Xi Cheng; Pinjia Wang; Yue Wang; Hong Zhang; Chuanmin Tao; Weiqing Yang; Mei Liu; Wenxiang Jia
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

5.  Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.

Authors:  G Meletis; N Vavatsi; M Exindari; E Protonotariou; E Sianou; C Haitoglou; D Sofianou; S Pournaras; E Diza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-06       Impact factor: 3.267

6.  Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa.

Authors:  G Meletis; M Exindari; N Vavatsi; D Sofianou; E Diza
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

Review 7.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

8.  MexXY multidrug efflux system of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

9.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

10.  A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa.

Authors:  Yoshimi Matsumoto; Shouichi Sakakihara; Andrey Grushnikov; Kazuma Kikuchi; Hiroyuki Noji; Akihito Yamaguchi; Ryota Iino; Yasushi Yagi; Kunihiko Nishino
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.